Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
About Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celldex Therapeutics
1
German High-Grade Non-Hodgkin's Lymphoma Study Group
1
Clinical Trials at Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
During the past decade, Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer
2013-11-01
2018-08-07
Completed
327
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are
"Lymphoma" (1 trials) and "Metastatic gpNMB Over-expressing Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" in a lesser frequency.
Clinical Trials Intervention Types at Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
Most popular intervention types in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are "Drug" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "CDX-011" (1 trials), "Capecitabine" (1 trials), "cyclophosphamide" (1 trials), "doxorubicin hydrochloride" (1 trials) and "pegfilgrastim" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
The vast majority of trials in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide" are
2 trials for "All" genders.
Clinical Trials Status at Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide
Currently, there are NaN active trials in "Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kliniken der Stadt Koeln gGmbH - Krankenhaus Holweide, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".